Labcorp Clinical Trials is a business segment of Labcorp Inc., a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Labcorp is a registered trademark and the marketing name for Labcorp Inc. and its subsidiaries around the world.
Caucasian Men and Women aged 20 to 65
8491404 Multiple
Back To Current StudiesCaucasian Men and Women aged 20 to 65
Study Number
8491404Group
MultipleGender
bothAge
20 - 65Location
Leeds, UKPayment
£2180 plus 2 travel paymentsStudy Dates
Aug. 21 - Oct. 06, 2022Additional Information
This study involves one 8 night stay, with one outpatient visit and one or two follow up calls.
Details
This study is available to Caucasian men and women aged 20-65 with a BMI between 18 and 30. Volunteers are allowed to be smokers, but must agree to refrain from smoking from 1 week prior to screening and check-in until after dosing. Gilberts syndrome is not acceptable. HRT is acceptable. There is a vegetarian menu available on this study.
Detailed Study Dates
Group 2b
Check in: 21 Aug 2022 Check out: 29 Aug 2022
Outpatient visit: 31 Aug 2022
Follow up call: 07 Sep 2022
***Follow up call: 06 Oct 2022 (females only)
Group 3b
Check in: 11 Sep 2022 Check out: 19 Sep 2022
Outpatient visit: 21 Sep 2022
Follow up call: 28 Sep 2022
***Follow up call: 27 Oct 2022 (females only)